Management EfficiencyThe company has return on total asset (ROA) of (10.27) % which means that it has lost $10.27 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (80.2) % meaning that it created substantial loss on money invested by shareholders.
Entity SummaryHemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in USA and traded on OTC Market. It employs 15 people.Hemagen Diagnostics (HMGN) is traded on OTC Market in USA. It is located in 9033 Red Branch Road and employs 15 people.
Hemagen Diagnostics Leadership Team
Stock Performance Indicators